chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna Dose 1 4/13/21 (016B21A) Moderna Dose 2 5/11/21 (021C21A) COVID Positive 12/31/2021  12/31/21: A 66-year-old female who has been living independently, but not doing well for several weeks, was brought to the emergency room with weakness, inability to ambulate, and very poor oral intake.  She has a history of dysphagia related to a burn in her throat.  Has not really been eating anything, unclear how much she has even been drinking.  She also has interstitial lung disease from previous x-rays, but has not really been on any treatment.  There is elevation of the left hemidiaphragm on chest x-rays. Again, etiology is somewhat unclear.  The patient smokes, but is unable to tell us how much she smokes.  The patient is a poor historian.  Most information is obtained from the emergency room staff and the EMS staff.  The patient is unable to tell us whether she has any medical problems.  She really is not aware of the date or actually where she is.  She cannot tell us the last time she had thing to eat or drink.  Does not know anything about her medical health.  She appears to be extremely dehydrated, decreased skin turgor and dry mucous membranes.  Her blood pressure is 80/50, pulse is 80 regular, oximetry is 97% on room air.  Chest x-ray shows infiltrates, but this may be related to interstitial lung disease, since she has not have leukocytosis or fever.  Unclear whether she has been tested for COVID-19. Cultures have been obtained.  IV antibiotics started for possible pneumonia with azithromycin and ceftriaxone.  She is being given IV fluids for possible sepsis, and she will probably remain in the emergency room until her blood pressure is above 95-100 systolic.  1/13/22: This patient with history of smoking had not been feeling well for several weeks.  She was admitted with severe dehydration, hypotension and anemia.  There was signs of GI bleeding and an upper endoscopy showed duodenal ulcers, and the colonoscopy showed a cecal polyp.  She did receive several units of blood.  She did test positive for COVID-19 but did not have hypoxemia or require specific antiviral therapy.  She was diagnosed with COVID on 12/30 and should be considered COVID recovered on 01/14.  Her blood pressure is still low and we have continued midodrine.  She did not want to go to a nursing home and will go home with a friend will provide much of her care. She has needed assistance getting out of bed into the bathroom.  She may be at high risk for readmission for complications of her multiple medical problems.  We have had a time replacing magnesium, and potassium.  If she can improve her overall nutrition, she should do well.
I received the vaccine at about 9:30 AM. From about 8:00 pm - 8:45 pm I experienced a pattern of 30-90 seconds of normal vision, then 1-2 seconds of only being able to see light/colors/shapes (I had lasik in 2016, my prescription was -4.75, the 1-2 seconds of bad vision I experienced was like when I removed my glasses before having lasik correct my vision). This pattern of 30-90 seconds normal vision then 1-2 seconds of bad vision repeated for about 45 minutes. During this time I was also very dizzy and lightheaded.   My other side effects were as expected (fever of up to 102, chills, VERY sweaty, did not have energy to remove my sweatshirt when I was hot, headache).  I am only reporting this in case it is important/helpful for further studies/development of the vaccine and public health.
SOB, LIPS/TONGUE TINGLING.  NO CYANOSIS OR RESP  DISTRESS. COLOR PINK, SKIN W/D.
shingles; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 5 days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was patient's husband. The age at vaccination was not reported. The patient got the new shingles vaccine and came down with shingles 5 days later. The reporter stated, no vaccine was 100 percent effective, please lie awake at night contemplating that fact for the next 20 years. The follow-up would not possible as no contact details were available.
Patient was vaccinated on 3/13/00 with one dose of measles virus vaccine live. In 1993, the patient had received a first dose of measles-mumps-rubella in Ukraine. On 3/17/00 the patient had her titer checked and was found to be non-imune. On 5/27/00 a repeat titer was drawn which revealed that the patient had not developed immunity.
2 days post vax, the pt developed a fine discrete red rash mostly on face, neck, and shoulders that itched. Also, red confluent palpable induration with rash on site of vax.
metallic taste in mouth & tongue; slight swelling of tongue; slight case of diarrhea
Patient received a Moderna COVID-19 vaccine dose from a 20 hours punctured vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a Moderna COVID-19 vaccine dose from a 20 hours punctured vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a Moderna COVID-19 vaccine dose from a 20 hours punctured vial). On 26-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patient received a Moderna COVID-19 vaccine dose from a 20 hours punctured vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.
Escherichia Coli infection; This is a spontaneous report from a non-contactable consumer (daughter) from a Pfizer sponsored program Pfizer First Connect. A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter's mother has Escherichia Coli infection and is taking Nitrofurantoin antibiotic (Macrodantin). Asked if it is safe to take the second dose of the vaccine while on antibiotic. Caller asking if we could update info regarding antibiotic as even her doctor does not have info on this. Saying that even her doctor is unsure as Pfizer should know information regarding this more than her doctor. Treatment for event was Nitrofurantoin antibiotic (Macrodantin). Outcome of event was unknown.    No follow up attempts are possible; Information about lot/batch number cannot be obtained.
Patient had swelling on arm that extend down to upper forearm after morning of the 3rd day (received shot on Saturday; swelling at upper foreman did not occur until Tuesday AM per patient. No other noted issues.
Patient only received the liquid; Patient only received the liquid; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were reported as follows: This case was reported by the office manager. The age at vaccination was not reported. The office manager stated that after doing a count, they noticed there was one vial of powder left. They thought a patient only received the liquid and not the powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter stated that they would have to research to try and narrow down the patient. The reporter consented to follow up.
Live vaccines (MMR and varicella) were administered to a patient on PROGRAF, an immunosuppressive drug. This is a contraindication.
After the 2nd dose I have had a permanent metallic taste to refluxed gastric or esophageal contents if I cough or am full. I have had a hiatal hernia for years but have never had this metallic taste before.
After receiving the first vaccine 3 week prior to this one (3/29/21) I had a vasovagal response a few minutes after.  After the second dose on 4/19/21, I did not have this same immediate response.   The following day I had expected symptoms of headache, fatigue, soreness in arm.  On the next day 4/21/21 i woke up feeling extremely fatigued, and felt heart palpitations.  I also started to get a sharp pain in my chest near my heart area.  I saw my cardiologist a few days later and wore a heart monitor for a week.  They observed I was having premature atrial contractions.  I was told the frequency was not an emergency issue.  (But I should note I never had these before).  Coupled with the pain in my chest I was worried about myocarditis. All symptoms began to decrease on may 14 and by may 17 were completely gone.   My echocardiogram wasn?t until may 26 2021, over a week after my symptoms stopped, and was normal.
This is a spontaneous report from a contactable consumer reporting for himself and from a contactable physician. A 76-year-old male patient received PREVNAR 13, (NDC 0005-1971-01) via intramuscular route on the left arm at 0.5 ml single on 15Jul2016 at 15:00, for immunization. On the same date and time the patient also received pneumococcal vaccine (PNU IMUNE 23, manufactured by Merck) intramuscular on the left arm for immunization. Medical history included ongoing hypertension, diagnosed for over 20 years. Concomitant medications included COZAAR, tablet 100 mg daily orally and ASPIRIN at 81 mg daily, both for hypertension. On unknown date in 2016 the patient experienced dry cough, pain, vaccination site warmth, muscle soreness, sensation of warmth on all his shoulder, his deltoids, shoulder pain, blood pressure jumped a little bit, discomfort in his hand, he was sick and hoarseness. The outcome of the events was reported as unknown except for dry cough from which the patient was not recovered. Follow-up (12Sep2016): New information reported from a contactable physician includes: suspect vaccine details (dose and NDC number of pneumococcal 13-val conj vac (dipht crm197 protein)), concomitant medication acetylsalicylic acid was added.
Rash appeared on both feet . Traveled to legs and trunk. Vasculitis legions on the arms . Rash has covered chest ,stomach.
Narrative: Breakthrough Covid-19: Pneumonia due to coronavirus disease 2019 and acute respiratory failure with hypoxia
I got the second vaccine on May and started to get periods every two weeks. I started to notice it at the end of June. This every two weeks "periods" happened until end of Sept or early Oct.
had body aches and muscle cramps day after recieving anthrax.  The cramping continued for 3 days after.
I felt  drunk, high, within the 15 minute waiting period at clinic and almost uncontiance  hours later at home??
Information has been received from a registered nurse concerning unknown number of patients who on an unknown dates were vaccinated with doses of PNEUMOVAX 23 (doses, routes and lot number not reported) which were stored at lower than recommended temperatures on multiple occasions. No adverse effect reported. This is one of several reports received from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. The health care professional contacted during telephone follow-up could not supply the following information: patients names, dates of birth, dates of vaccination/therapy, dose number, lot number, date of event, healthcare provider name and contact information. Additional information has been requested.
After first dose, neuropathy and body twitching, but this passed. After second vaccine, ended up with neuropathy within a few days of the vaccine - buzzing and tingling in my feet and hands and lower legs, and diagnosed with small fiber neuropathy by neurologist and other causes were ruled out. Symptoms are persistent and worsening over time.
WORSENING OF CHRONIC PAROSMIA; WORSENING OF ANOSMIA/LOSS OF SMELL; LOSS OF TASTE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: chronic parosmia, and chronic anosmia. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced worsening of chronic parosmia, worsening of anosmia/loss of smell, and loss of taste. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the loss of taste, worsening of anosmia/loss of smell and worsening of chronic parosmia was not reported. This report was non-serious.
I woke up in the middle of the night (not sure what time) with splitting pain in my head--so bad that all my teeth hurt too, but also my face had gone numb/tingly. I remember specifically touching my lips and cheeks and they had almost no sensation. It was like the feeling of being numbed for dental work. I am not sure if it was both sides of my face or only one because I was in and out of sleep so it's hard to remember. I also don't know how long it lasted because I didn't get up--I just tried to fall back to sleep. By the time I woke up around 8am, I felt totally normal and had no pain or numbness anywhere. I didn't report it at the time because I had a doctor tell me it was normal, but today when I got my second dose, the (different) doctor who administered it said he'd never heard of that and that I should report it.
About several hours the patient received a flu vaccine, he felt dizzy. He then felt like he couldn't control his hands or feet and had trouble walking. Over the next week he felt like he had a flu like illness with nausea and diarrhea. It gradually improved, though he still felt like his balance was off when I saw him today. I wonder whether he had a Guillain-Barre like reaction.
Dizziness starting around 8:30 PM, fever from 10 PM to sometime after 3 AM, syncope x2 around 8:30 AM
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 13:15 as dose 5 (booster), single (Lot number: GH9693) at the age of 75 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "migraine headaches" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing); "known allergies: soy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 25Aug2023 to 29Aug2023.
He got COVID a week after her; He got COVID a week after her; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date 20Mar2021 (Lot number: EP6955) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2021, outcome "unknown" and all described as "He got COVID a week after her". The patient's wife was diagnosed with COVID on 01Apr2021. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Apr2021) positive, notes: He got COVID a week after her because he drank after her.
Took 1st dose Vivotif. After 24 hrs felt achy, nauseated and faint within 36 hours he developed night sweats which continued 2/1 night. 48 hours post dose he feels very weak. After discussion he decided to take 2nd dose at 70 hrs. 18 hrs post dose he says he has slight abd cramping but no other Sx.
pt devel muscle soreness 1 to 2 days p/vax;then devel muscle pain, numbness in extremities & lips, diff swallowing;pt hosp 17OCT96 & on 18OCT96 neurologist dx GBS;pt being treated w/albumin plasma exchange;
Information has been received from a medical assistant referring to an unknown number of patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were not reported. On unknown dates in 2016 (reported as starting on or after 06-JUL-2016), the patients were vaccinated with doses of VARIVAX (lot # L020002 with expiration date 02-JUN-2017, lot # M000757 with expiration date 06-JAN-2018, dose and route were not reported). The vaccine had been stored under the temperature of 9 Fahrenheit degree for 9 hours. There was no previous temperature excursion. Digital data logger involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
shivers/chills/fatigue 10-12 hours after vaccine, spent 36 hours in bed with fatigue, headache, muscle aches, nausea, didn't eat or drink anything for past 24 hours, lost 5 lbs in the last 2 days, today I'm partially improved
blood pressure was up pretty high; her face was blood red; pain; This is a spontaneous report from a contactable consumer or other non hcp. A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration, administered in Arm Left on 03Mar2021 11:00 (at the time of vaccination 71-years-old), as a SINGLE DOSE for COVID-19 immunization. The patient's medical history included, flu shot for immunization, which was way back in Sep2020; degenerative spinal arthritis, she has degenerative spinal arthritis which were diagnosed in her 30's; blockage with high cholesterol, Caller states she has degenerative spinal arthritis and has a blockage with high cholesterol and states the high cholesterol was diagnosed 15 years ago; fibromyalgia; Sleep disorder; several ruptured discs and is in pain management. The patient's concomitant medications included simvastatin (SIMVASTATIN); nabumetone (NABUMETONE); methocarbamol (METHOCARBAMOL) taken for fibromyalgia, spinal osteoarthritis; pregabalin (LYRICA) from 1990 to an unspecified stop date; trazodone (TRAZODONE) taken for sleep disorder; and nortriptyline (NORTRIPTYLINE) taken for sleep disorder. On an unspecified date, the patient experienced blood pressure was up pretty high, her face was blood red, and pain. The patient stated that, her blood pressure normally runs 120/70; and blood pressure measurement was 140, after the vaccine her blood pressure was way above 140. On an unspecified date, the patient underwent lab tests which included blood pressure measurement: 120/70. The outcome of the event blood pressure was up pretty high was recovered on an unspecified date, and other events outcome were unknown.  No follow-up attempts are Possible. No further information is expected.
Presented to ED on 12/29/21 and found to be COVID positive. Received pfizer on 09/02/21 and 09/25/21. ER with complaints of vomiting for the past day.  Patient had a CT scan of his abdomen done which revealed cholecystitis so an ultrasound was done which confirmed cholecystitis with small gallstones. Patient denies any abdominal pain.  Denies any fevers or chills.   Patient also incidentally tested positive for COVID. He was asymptomatic. Admitted for cholecystitis not COVID. Discharged on 12/31/21
Feb. 14 to March: signs of depression, anxiety, weight loss. Checked in with family doctor. It was discovered she was given the vaccine WITHOUT PERMISSION FROM BIRTH MOTHER. Discoloration under eyes, around nose lasting 2 days. Rash on throat/discoloration of skin. March: severe pain in right arm unable to lift or move. Lasted until next day. Next was right leg pain. Couldn't walk or move. Pain moved to stomach, caused vomiting until midday and pain never left though she was no longer nauseaous able to eat fruits and drink water. Next day pain went to heel, felt like a stabbing pain, couldn't walk. This continued everyday for 4 days. Next pain moved to right underarm pit and inner elbow, to tender to touch, pain last 2 to almost 3 hours. Has pain throughout night while sleeping. Pain moved up her spine, couldn't move back, was very uncomfortable. Next day stomach pain, couldn't move rested most of the day and her right pinky toe started hurting excessively couldn't wear socks or shoes, showing signs or swelling and redness on toe. Her pain moved to her head waking up she was dizzy, pale, fatigued. Went to family doctor for more advice/help, we are not going for blood work and a thyroid ultrasound.
Erythematous maculopapular rash on trunk, extremities including soles & palms on day 12.
Pain, swelling and redness of injection site associated to chills and axillary adenopathy. Site to Tdap.
daughter received her third GARDASIL 9 vaccination a month earlier than scheduled; daughter received her third GARDASIL 9 vaccination a month earlier than scheduled; no adverse reactions reported; This spontaneous report was received from a consumer and refers to a female patient of an unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown dates, the patient was vaccinated with her first and second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (frequency, route of administration, anatomical location, lot # and expiration date were not provided). On an unknown date, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) a month earlier than scheduled. There were no adverse reactions reported.
on March 18, 2021 ( the day following my J&J vaccination ), While on my way back from a 2 mile run , I experienced left-sided listing and lack of control of my left leg and arm.  I was dizzy and saw black spots.  My wife and son took me to  emergency room.  My symptoms abated while at the hospital.  Hospital staff conducted many tests and I was kept overnight and discharged the next day around 5:00 p.m. with possible TIA as diagnosis.
Blood and mucus in stool, slight irritability 5 days after Rotateq. Monitoring.